Skip to main content

Table 1 The correlations between CBX7 expression and clinicopathologic variables, and p16 expression

From: Oncogenic role of the chromobox protein CBX7 in gastric cancer

Variables CBX7 n (%)  
  (-) (+) P value*
Gender    
   Male 34(68.0) 16(32.0)  
   Female 16(64.0) 9(36.0) 0.729
Age (years)    
   <60 15(50.0) 15(50.0)  
   ≥60 35(77.8) 10(22.2) 0.012
Size(cm)    
   <4.5 26(65.0) 14(35.0)  
   ≥4.5 24(68.6) 11(31.4) 0.743
Histology    
   Well differentiated 22(71.0) 9(29.0)  
   Poorly differentiated 28(63.6) 16(36.4) 0.507
T classification    
   T1/2 19(76) 6(24)  
   T3/4 31(62.0) 19(38.0) 0.605
LNM    
   Negative 31(77.5) 9(22.5)  
   Positive 19(54.29) 16(45.71) 0.035
Distant metastasis    
   Negative 48(82.76) 21(17.24)  
   Positive 2(56.52) 4(43.48) 0.071
Clinical stage    
   I/II 24(84.6) 5(15.4)  
   III/IV 26(60.0) 20(40.0) 0.02
p16    
   Negative 18(58.1) 13(41.9)  
   Positive 32(72.7) 12(27.3) 0.188
  1. Abbreviations: LNM, lymph node metastasis. *Data were analyzed by the χ2-test and p < 0.05 was considered to be significant.